Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
Pneumonia
About this trial
This is an interventional treatment trial for Pneumonia focused on measuring Children, Non-severe pneumonia, Oral amoxicillin
Eligibility Criteria
Inclusion Criteria: They are aged 2-59 months. Diagnosed with WHO defined non-severe pneumonia Exclusion Criteria: Children with signs of WHO defined severe or very severe disease. Known penicillin allergy, with a history of accelerated rash, urticaria, or anaphylactic symptoms. Complicating acute non-pulmonary or chronic illness. The children living outside the municipal limits of the city who cannot be followed up. Children who have taken the appropriate doses of WHO-recommended dose of antimicrobial drug for 48 hours prior to presentation. Children who have prior history of wheezing or bronchial asthma and are wheezing now. Children whose parents or guardians refuse to give consent. Previously enrolled patients in the present study. Hospitalization in the past two weeks.
Sites / Locations
- ARI Research Cell, Children Hospital, Pakistan Institute of Medical Sciences